Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Exposure to indoor dampness was upgraded from class II to class I evidence, exposure to indoor mold was upgraded from class III to class I evidence, active exposure to tobacco smoking was upgraded from not significant to class II evidence, and vitamin D status was downgraded from class IV to not significant.

Source: Environmental Risk Factors and Protective Factors. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Environmental Risk Factors, Protective Factors, and Biomarkers for Allergic Rhinitis: A Systematic Umbrella Review of the Evidence

Source: Article title.

The types of articles we included were systematic reviews and meta-analyses, which mainly studied the association of environmental factors or biomarkers with AR.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Environmental Risk Factors, Protective Factors, and Biomarkers for Allergic Rhinitis: A Systematic Umbrella Review of the Evidence

Systematic review · Clinical Reviews in Allergy & Immunology · 2023

Original publication title

Environmental Risk Factors, Protective Factors, and Biomarkers for Allergic Rhinitis: A Systematic Umbrella Review of the Evidence

Xianpeng Xu; Xinghong Liu; Jiongke Li; Xinxing Deng; Tianrong Dai; Qingjie Ji; Dajing Xiong; Hui Xie

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Many potential environmental risk factors, protective factors, and biomarkers of AR have been published, but so far, the strength and consistency of their evidence are unclear. We conducted a comprehensive review of environmental risk, protective factors, and biomarkers for AR to establish the evidence hierarchy. We systematically searched Embase, PubMed, Cochrane Library, and Web of Science electronic database from inception to December 31, 2022. We calculated summary effect estimate (odds ratio (OR), relative risk (RR), hazard ratio (HR), and standardized mean difference (SMD)), 95% confidence interval, random effects p value, I2 statistic, 95% prediction interval, small study effects, and excess significance biases, and stratification of the level of evidence.

Methodological quality was assessed by AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews 2). We retrieved 4478 articles, of which 43 met the inclusion criteria. The 43 eligible articles identified 31 potential environmental risk factors (10,806,206 total population, two study not reported), 11 potential environmental protective factors (823,883 total population), and 34 potential biomarkers (158,716 total population) for meta-analyses. The credibility of evidence was convincing (class I) for tic disorders (OR = 2.89, 95% CI 2.11 to 3.95); and highly suggestive (class II) for early-life antibiotic use (OR = 3.73, 95% CI 3.06 to 4.55), exposure to indoor dampness (OR = 1.49, 95% CI 1.27 to 1.75), acetaminophen exposure (OR = 1.54, 95% CI 1.41 to 1.69), childhood acid suppressant use (OR = 1.40, 95% CI 1.23 to 1.59), exposure to indoor mold (OR = 1.66, 95% CI 1.26 to 2.18), coronavirus disease 2019 (OR = 0.11, 95% CI 0.06 to 0.22), and prolonged breastfeeding (OR = 0.72, 95% CI 0.65 to 0.79).

This study is registered in PROSPERO (CRD42022384320).

Supplementary Information

The online version contains supplementary material available at 10.1007/s12016-023-08964-2.

Authors’ abstract

Many potential environmental risk factors, protective factors, and biomarkers of AR have been published, but so far, the strength and consistency of their evidence are unclear. We conducted a comprehensive review of environmental risk, protective factors, and biomarkers for AR to establish the evidence hierarchy. We systematically searched Embase, PubMed, Cochrane Library, and Web of Science electronic database from inception to December 31, 2022. We calculated summary effect estimate (odds ratio (OR), relative risk (RR), hazard ratio (HR), and standardized mean difference (SMD)), 95% confidence interval, random effects p value, I2 statistic, 95% prediction interval, small study effects, and excess significance biases, and stratification of the level of evidence.

Methodological quality was assessed by AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews 2). We retrieved 4478 articles, of which 43 met the inclusion criteria. The 43 eligible articles identified 31 potential environmental risk factors (10,806,206 total population, two study not reported), 11 potential environmental protective factors (823,883 total population), and 34 potential biomarkers (158,716 total population) for meta-analyses. The credibility of evidence was convincing (class I) for tic disorders (OR = 2.89, 95% CI 2.11 to 3.95); and highly suggestive (class II) for early-life antibiotic use (OR = 3.73, 95% CI 3.06 to 4.55), exposure to indoor dampness (OR = 1.49, 95% CI 1.27 to 1.75), acetaminophen exposure (OR = 1.54, 95% CI 1.41 to 1.69), childhood acid suppressant use (OR = 1.40, 95% CI 1.23 to 1.59), exposure to indoor mold (OR = 1.66, 95% CI 1.26 to 2.18), coronavirus disease 2019 (OR = 0.11, 95% CI 0.06 to 0.22), and prolonged breastfeeding (OR = 0.72, 95% CI 0.65 to 0.79).

This study is registered in PROSPERO (CRD42022384320).

Supplementary Information

The online version contains supplementary material available at 10.1007/s12016-023-08964-2.

Publication and source details

Original title: Environmental Risk Factors, Protective Factors, and Biomarkers for Allergic Rhinitis: A Systematic Umbrella Review of the Evidence

Xianpeng Xu; Xinghong Liu; Jiongke Li; Xinxing Deng; Tianrong Dai; Qingjie Ji; Dajing Xiong; Hui Xie

Clinical Reviews in Allergy & Immunology · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.National famous Traditional Chinese Medicine Inheritance Studio construction project500006008500006008Xiong Dajing Xie Hui

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T17:18:20.505132+00:00

DOI: 10.1007/s12016-023-08964-2 · PMC10567804